News & Press Releases

Members Esteban Morales and Arameh O'Boyle published an article in Bloomberg Law predicting consumer class actions will increase due to evolving state and federal laws affecting telemarketing, online privacy, product labeling, and auto-renewal practices. The authors advise businesses to closely monitor these developments and strengthen arbitration clauses and class action waivers to reduce litigation risk.  

Law360 Pulse featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.

Bloomberg Law featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.

Sige Gutman, Life Sciences Litigation Practice Chair, shared insights with IAM in an article about a decision by the US District Court for the District of Delaware which found that a gene therapy patent of RegenxBio and the Trustees of the University of Pennsylvania was ineligible and granted summary judgement in favor of Sarepta Therapeutics.  

Communications Daily featured insights from Member Esteban Morales in an article about a ruling from the 5th U.S. Circuit Court of Appeals which said that despite an FCC ruling that required prior written consent for telemarketing calls, the Telephone Consumer Protection Act indicates that oral consent is enough.  

Mergermarket recently featured insights from Cheryl Reicin, Life Sciences Practice Co-chair, in an article discussing a potential 2026 rebound in M&A activity across the contract development and manufacturing organization (CDMO) sector, which provides outsourced development and manufacturing services to biopharma and medical‑device companies.